A new study at the health system department of the University of Virginia has revealed that a diabetes drug could help to treat Alzheimer’s disease. Piogliatzone HCI, a type 2 diabetes drug, could help Alzheimer’s patients.
Alzheimer’s is a disease that ruins the cognitive function of the brain, destroying memories and often straining relationships. It is also common, with 4.5 million sufferers in the United States.
The study was reported at the largest Alzheimer’s conference in the world, ICAD, held in Madrid, Spain . The news comes following further recent links between diabetes and Alzheimer’s. Dr. Geldmacher, an expert involved in the study, stated that: “We believe that the drug may reduce the body’s inflammatory reaction to one of the toxic components that builds up in Alzheimer’s, called amyloid plaque.”
He continued: “We don’t know exactly how pioglitazone works in Alzheimer’s, but there are two possibilities. It could be that the drug reduces the body’s response to the amyloid protein found in Alzheimer’s. Or, it could be that this drug helps brain cells function. The real advantage is that it’s a completely novel approach to treating the disease.”
The news has positive implications for Alzheimer’s sufferers, who could see the major symptoms of their disease staved off by the drug.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…